Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review
Third-generation intravenous (i.v.) iron preparations are safe and efficacious and are increasingly used in the treatment of iron-deficiency anaemia. Hypophosphataemia is emerging as an established side-effect following the administration of certain compounds. Symptoms of hypophosphataemia can be ma...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2021-01-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | https://www.drugsincontext.com/hypophosphataemia,-fibroblast-growth-factor-23,-and-third-generation-intravenous-iron-compounds:-a-narrative-review |